⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RDHL News
Redhill Biopharma Ltd.
Ebola Cases and Deaths Rapidly Mount - RedHill Updates on Opaganib Emergency Outbreak Development
prnewswire.com
RDHL
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
prnewswire.com
RDHL
CPIX
RedHill Biopharma Announces Up To $19.4 Million Private Placement
prnewswire.com
RDHL
CPIX
RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
prnewswire.com
RDHL
CPIX
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
prnewswire.com
RDHL
CPIX
RedHill Biopharma Advancing Opaganib Options For Ebola Virus Disease Outbreak
prnewswire.com
RDHL
RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms
prnewswire.com
RDHL
Hepatic Encephalopathy Market Set for Growth at a 1.2% CAGR Through 2036, Driven by Emerging Therapies and Rising Disease Burden | DelveInsight
globenewswire.com
VNDA
GRFS
BHC
RDHL
MRK
TEVA
PFE
SNY
LLY
ABBV
AZN
CRCT
SPRO
CRNX
RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease
prnewswire.com
RDHL
CPIX
RedHill Biopharma Announces Full-Year 2025 Financial Results and Operational Highlights
prnewswire.com
RDHL
CPIX